Laemmerer A, Lehmann C, Mayr L, Bruckner K, et al. Alternative lengthening of telomere-based immortalization renders H3G34R -mutant diffuse hemispheric glioma hypersensitive to PARP inhibitor combination regimens. Neuro Oncol 2024 Nov 18:noae228. doi: 10.1093.
PMID: 39556024